|
1
|
Humbert M, Morrell NW, Archer SL, Stenmark
KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O,
Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology
of pulmonary arterial hypertension. J Am Coll Cardiol. 43:(12 Suppl
S). 13S–24S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sudar E, Dobutovic B, Soskic S, Mandusic
V, Zakula Z, Misirkic M, Vucicevic L, Janjetovic K, Trajkovic V,
Mikhailidis DP and Isenovic ER: Regulation of inducible nitric
oxide synthase activity/expression in rat hearts from
ghrelin-treated rats. J Physiol Biochem. 67:195–204. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orlandi A, Bochaton-Piallat ML, Gabbiani G
and Spagnoli LG: Aging, smooth muscle cells and vascular
pathobiology: Implications for atherosclerosis. Atherosclerosis.
188:221–230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stenmark KR, Fagan KA and Frid MG:
Hypoxia-induced pulmonary vascular remodeling: Cellular and
molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo Y, Xu DQ, Dong HY, Zhang B, Liu Y, Niu
W, Dong MQ and Li ZC: Tanshinone IIA inhibits hypoxia-induced
pulmonary artery smooth muscle cell proliferation via
Akt/Skp2/p27-associated pathway. PLoS One. 8:e567742013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vasa M, Fichtlscherer S, Adler K, Aicher
A, Martin H, Zeiher AM and Dimmeler S: Increase in circulating
endothelial progenitor cells by statin therapy in patients with
stable coronary artery disease. Circulation. 103:2885–2890. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen B, Calvert AE, Cui H and Nelin LD:
Hypoxia promotes human pulmonary artery smooth muscle cell
proliferation through induction of arginase. Am J Physiol Lung Cell
Mol Physiol. 297:L1151–L1159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dennis JW, Pawling J, Cheung P, Partridge
E and Demetriou M: UDP-N-acetylglucosamine: Alpha-6-D-mannoside
beta1, 6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
Biochim Biophys Acta. 1573:414–422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sharma UC, Pokharel S, van Brakel TJ, van
Berlo JH, Cleutjens JP, Schroen B, André S, Crijns HJ, Gabius HJ,
Maessen J and Pinto YM: Galectin-3 marks activated macrophages in
failure-prone hypertrophied hearts and contributes to cardiac
dysfunction. Circulation. 110:3121–3128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thijssen VL, Hulsmans S and Griffioen AW:
The galectin profile of the endothelium: Altered expression and
localization in activated and tumor endothelial cells. Am J Pathol.
172:545–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wan SY, Zhang TF and Ding Y: Galectin-3
enhances proliferation and angiogenesis of endothelial cells
differentiated from bone marrow mesenchymal stem cells. Transplant
Proc. 43:3933–3938. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dumic J, Dabelic S and Flögel M:
Galectin-3: An open-ended story. Biochim Biophys Acta.
1760:616–635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papaspyridonos M, McNeill E, de Bono JP,
Smith A, Burnand KG, Channon KM and Greaves DR: Galectin-3 is an
amplifier of inflammation in atherosclerotic plaque progression
through macrophage activation and monocyte chemoattraction.
Arterioscler Thromb Vasc Biol. 28:433–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu X, Murphy TC, Nanes MS and Hart CM:
PPAR{gamma} regulates hypoxia-induced Nox4 expression in human
pulmonary artery smooth muscle cells through NF-{kappa}B. Am J
Physiol Lung Cell Mol Physiol. 299:L559–L566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henderson NC, Mackinnon AC, Farnworth SL,
Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J and Sethi T:
Galectin-3 expression and secretion links macrophages to the
promotion of renal fibrosis. Am J Pathol. 172:288–298. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu L, Quinn DA, Garg HG and Hales CA: Gene
expression of cyclin-dependent kinase inhibitors and effect of
heparin on their expression in mice with hypoxia-induced pulmonary
hypertension. Biochem Biophys Res Commun. 345:1565–1572. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong Y, Sui L, Sugimoto K, Tai Y and
Tokuda M: Cyclin D1-CDK4 complex, a possible critical factor for
cell proliferation and prognosis in laryngeal squamous cell
carcinomas. Int J Cancer. 95:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Campen MJ, Paffett ML, Colombo ES, Lucas
SN, Anderson T, Nysus M, Norenberg JP, Gershman B, Hesterman J,
Hoppin J and Willis M: Muscle RING finger-1 promotes a maladaptive
phenotype in chronic hypoxia-induced right ventricular remodeling.
PLoS One. 9:e970842014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JW, Kim HS, Kim S, Hwang J, Kim YH,
Lim GY, Sohn WJ, Yoon SR, Kim JY, Park TS, et al: DACH1 regulates
cell cycle progression of myeloid cells through the control of
cyclin D, Cdk 4/6 and p21Cip1. Biochem Biophys Res Commun.
420:91–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hutcheson R, Terry R, Chaplin J, Smith E,
Musiyenko A, Russell JC, Lincoln T and Rocic P: MicroRNA-145
restores contractile vascular smooth muscle phenotype and coronary
collateral growth in the metabolic syndrome. Arterioscler Thromb
Vasc Biol. 33:727–736. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rensen SS, Doevendans PA and van Eys GJ:
Regulation and characteristics of vascular smooth muscle cell
phenotypic diversity. Neth Heart J. 15:100–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hashmi S and Al-Salam S: Galectin-3 is
expressed in the myocardium very early post-myocardial infarction.
Cardiovasc Pathol. 24:213–223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ikemori RY, Machado CM, Furuzawa KM,
Nonogaki S, Osinaga E, Umezawa K, de Carvalho MA, Verinaud L and
Chammas R: Galectin-3 up-regulation in hypoxic and nutrient
deprived microenvironments promotes cell survival. PLoS One.
9:e1115922014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mor A, Planer D, Luboshits G, Afek A,
Metzger S, Chajec-Shaul T, Keren G and George J: Role of naturally
occurring CD4+ CD25+ regulatory T cells in experimental
atherosclerosis. Arterioscler Thromb Vasc Biol. 27:893–900. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hassoun PM, Mouthon L, Barberà JA,
Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML,
Michelakis ED, Morrell NW, et al: Inflammation, growth factors, and
pulmonary vascular remodeling. J Am Coll Cardiol. 54:(Suppl 1).
S10–S19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chaouat A, Savale L, Chouaid C, Tu L,
Sztrymf B, Canuet M, Maitre B, Housset B, Brandt C, Le Corvoisier
P, et al: Role for interleukin-6 in COPD-related pulmonary
hypertension. Chest. 136:678–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Q, Zuo XR, Wang YY, Xie WP, Wang H
and Zhang M: Monocrotaline-induced pulmonary arterial hypertension
is attenuated by TNF-α antagonists via the suppression of TNF-α
expression and NF-κB pathway in rats. Vascul Pharmacol. 58:71–77.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fouty BW, Grimison B, Fagan KA, Le Cras
TD, Harral JW, Hoedt-Miller M, Sclafani RA and Rodman DM: p27(Kip1)
is important in modulating pulmonary artery smooth muscle cell
proliferation. Am J Respir Cell Mol Biol. 25:652–658. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Y, Lv M, Lin H, Cui Y, Wei X, Qin Y,
Kohama K and Gao Y: Rho-associated protein kinase isoforms
stimulate proliferation of vascular smooth muscle cells through ERK
and induction of cyclin D1 and PCNA. Biochem Biophys Res Commun.
432:488–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arteaga CL: Cdk inhibitor p27Kip1 and
hormone dependence in breast cancer. Clin Cancer Res. 10:(Suppl).
368S–371S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Akyurek LM, Boehm M, Olive M, Zhou AX, San
H and Nabel EG: Deficiency of cyclin-dependent kinase inhibitors
p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein
E-deficient mice. Biochem Biophys Res Commun. 396:359–363. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanner FC, Boehm M, Akyurek LM, San H,
Yang ZY, Tashiro J, Nabel GJ and Nabel EG: Differential effects of
the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1) and
p16(Ink4) on vascular smooth muscle cell proliferation.
Circulation. 101:2022–2025. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wali MA and Eid RA: Smooth muscle changes
in varicose veins: An ultrastructural study. J Smooth Muscle Res.
37:123–135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Naoum JJ, Hunter GC, Woodside KJ and Chen
C: Current advances in the pathogenesis of varicose veins. J Surg
Res. 141:311–316. 2007. View Article : Google Scholar : PubMed/NCBI
|
